WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today issued the following statement from Ashley Wittorf, Executive Director, AdvaMed Accel & Global Head, Investor Relations, on bipartisan legislation (HR 7917) introduced in the U.S. House of Representatives which will provide economic relief to small medtech companies impacted by the COVID-19 pandemic:
Top News
Press Release | August 5, 2020
Press Release | August 4, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests reached approximately 100 million, as of July 25, based on the latest data from the association’s national testing registry.
Press Release | August 3, 2020
WASHINGTON, D.C. – To ensure production of vital medical devices and diagnostic tests during this critical time and to help prevent future supply chain issues, the Advanced Medical Technology Association (AdvaMed) announced that it is expanding the VentConnect platform. The new MedDeviceNetwork platform (MedDeviceNetwork.org) will move beyond ventilators to include other complex medical technologies America’s patients and caregivers need in the continuing fight against COVID-19 and other future health care emergencies.
Events
August
13
August 13, 2020 |
Businesses continue to confront unprecedented and daunting challenges in reopening and returning to work while ensuring a safe workplace. New obligations and responsibilities for employers mean that... Read More
October
05
October 5, 2020 to October 7, 2020
| The Virtual MedTech Conference will bring together the world's top medtech executives and innovators to network, conduct business, gain access to capital and share insights in an engaging digital... Read More
Featured Video
We thank our member companies for their continued efforts to mobilize for health care workers on the frontlines. Learn more about how the industry has come together in the fight against COVID-19.
Industry News
Denver, Colo., June 11, 2020 — The Association of periOperative Registered Nurses (AORN) today announced survey results of more than 1000 surgical nurse leaders in the United States regarding how their facilities are managing the resumption of elective surgeries. The survey results are intended to help medical device manufacturers understand their customers’ pace and product needs as ORs ramp up their efforts to return to full surgical volume. With this information, industry can plan their...
SAN DIEGO, May 27, 2020 /PRNewswire/ -- MVPvets, a 501c(3) nonprofit organization that assists and prepares transitioning military veterans for meaningful employment in life science companies, announced the appointment of new Chairman of its Board of Directors, Capt. Derek Herrera, USMC (Ret.). Herrera has been actively involved as an MVPvets board member since early 2019. He succeeds outgoing Chairman Michael R. Minogue, the Chairman, President and Chief Executive Officer of Abiomed, who has...
BOTHELL, Wash., May 20, 2020 /PRNewswire/ -- FUJIFILM Sonosite, Inc., the world leader in point-of-care ultrasound, has announced Rich Fabian, the company's President and Chief Operating Officer, was appointed to the board of The Advanced Medical Technology Association (AdvaMed), a Washington D.C.-based trade association that leads the effort to advance medical technology in order to achieve healthier lives and healthier economies around the world.
Martinez, CA, USA – March 26, 2020 – Treatment of COVID-19 with ExThera’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has begun in hospitals in Germany and Italy. Seraph 100 treatments of COVID-19 are also expected to begin soon in France and the USA.
Seraph 100 is the only ‘hemoperfusion device’ approved for the reduction of pathogens in blood. In recent EU clinical cases improved lung function and rapid reduction of drug-resistant bacterial pathogens occurred with Seraph 100...
HAYWARD, Calif.--RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT)* to treat all stages of cancer today announced it has received marketing clearance from the U.S. Food & Drug Administration (FDA) for stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT) for its RefleXion™ X1 machine.
“We are at the forefront of an enormous change in expanding the use of radiotherapy from a...
Twitter Feed
August 7, 2020 - 4:58pm
The IGNITE American Innovation Act will help spur the creation of more cutting-edge U.S #medtech companies. Learn m… https://t.co/omIfbPIzVh
August 7, 2020 - 4:10pm
“The diagnostics industry will continue to work 24/7, around the clock, to ensure widespread availability of test k… https://t.co/SgAPmoGfFI